Our “highly regarded” life sciences arbitration lawyers are renowned for their “expert handling of life sciences disputes” (Chambers 2020), and “understanding of the needs of life sciences companies” (Legal 500 USA 2022).
From strategically drafting arbitration clauses and formulating dispute avoidance strategies, to effectively representing life sciences companies before arbitral tribunals and courts in related litigation, our life sciences arbitration team can help you successfully navigate all phases of a cross-border life sciences dispute, including disputes with foreign governments.
In addition to acting as counsel, members of our life sciences arbitration team routinely sit as arbitrators and play leading roles in major arbitral institutions. We are recognized globally as thought leaders in the arbitration arena, affording us unique tools for effectively resolving life sciences arbitrations and adding to our “strong experience across both advisory and contentious matters” (Chambers 2020).
We draw on expertise from across our multidisciplinary global life sciences practice – which represents many of the world’s largest pharmaceutical and medical device manufacturers – to build teams that provide holistic and comprehensive advice for life sciences arbitrations seated in the United States, Europe, Asia, the Middle East, Africa and Latin America under a host of governing laws.
Our life sciences arbitration lawyers anticipate and solve legal challenges so that our life sciences clients, who range from the largest multinational pharmaceutical and device manufacturers to start-ups and investors, can protect and grow their businesses.
Life sciences clients, including companies at all development phases, trust us with their most significant commercial life sciences disputes. We build that trust by marrying our deep life sciences industry expertise with our exceptional arbitration skills, which results in superior client service. We represent life sciences clients in a range of commercial disputes, including product development and commercialization, manufacturing, supply and distribution, all forms of collaboration and partnering, licensing, regulatory, intellectual property, post-M&A and investment matters. In short, we offer a one-stop solution for all of your commercial life sciences dispute resolution needs so that you can focus on getting back to business.
We solve cross-border disputes by offering practical commercial solutions that emanate from our keen understanding of the life sciences industry.
Our international arbitration team members are known throughout the arbitration community by counsel, arbitrators and arbitral institutions. Team members sit on the ICC Commission on Arbitration and ADR, and the ICDR Life Sciences Steering Committee, and are listed on the arbitrator rosters of most major arbitral institutions, including the AAA/ICDR Life Sciences Arbitrator Roster. Team members understand the current issues that impact the industry and are routinely asked to comment on those issues for publications such as Law 360, Inside Health Policy and the European Pharmaceutical Review.
Our experienced investor-state arbitration team knows how to protect foreign life sciences investments by structuring those investments to maximize treaty protection, negotiating commercial solutions with host governments, and bringing investor-state claims under bilateral and multilateral investment treaties to compel those outcomes when necessary.